Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume
Jun 4, 2026
Purchase
Shares
50,000
Price
$9.31
Total Value
$465.29K
Shares Held After
936,000
% of Holdings
5.3%

VERACYTE, INC. (VCYT)

Stapley Marc — Director
Jun 4, 2026
Sale
Shares
138,051
Price
$50.12
Total Value
$6.92M
Shares Held After
440,494
% of Holdings
23.9%

VERACYTE, INC. (VCYT)

Chambers Rebecca — Chief Financial Officer
Jun 4, 2026
Sale
Shares
1,961
Price
$50.09
Total Value
$98.23K
Shares Held After
173,280
% of Holdings
1.1%

VERACYTE, INC. (VCYT)

Chambers Rebecca — Chief Financial Officer
Jun 4, 2026
Sale
Shares
1,600
Price
$49.28
Total Value
$78.85K
Shares Held After
175,241
% of Holdings
0.9%

VERACYTE, INC. (VCYT)

McGuire Annie — EVP, General Counsel
Jun 4, 2026
Sale
Shares
1,776
Price
$50.12
Total Value
$89.01K
Shares Held After
137,240
% of Holdings
1.3%

VERACYTE, INC. (VCYT)

McGuire Annie — EVP, General Counsel
Jun 4, 2026
Sale
Shares
1,400
Price
$49.31
Total Value
$69.03K
Shares Held After
139,016
% of Holdings
1.0%

VERACYTE, INC. (VCYT)

Leite John — Global Chief Commercial Off
Jun 4, 2026
Sale
Shares
13,975
Price
$50.07
Total Value
$699.73K
Shares Held After
132,305
% of Holdings
9.6%
Jun 4, 2026
Purchase
Shares
100,000
Price
$14.60
Total Value
$1.46M
Shares Held After
25,824,474
% of Holdings
0.4%
Jun 4, 2026
Purchase
Shares
100,000
Price
$14.60
Total Value
$1.46M
Shares Held After
25,824,474
% of Holdings
0.4%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
1,250
Price
$549.47
Total Value
$686.84K
Shares Held After
45,172
% of Holdings
2.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
593
Price
$549.49
Total Value
$325.85K
Shares Held After
46,422
% of Holdings
1.3%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
1,481
Price
$548.42
Total Value
$812.22K
Shares Held After
47,015
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
935
Price
$547.11
Total Value
$511.55K
Shares Held After
48,496
% of Holdings
1.9%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
2,627
Price
$546.42
Total Value
$1.44M
Shares Held After
49,431
% of Holdings
5.0%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
374
Price
$545.27
Total Value
$203.93K
Shares Held After
52,058
% of Holdings
0.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
840
Price
$543.89
Total Value
$456.87K
Shares Held After
52,432
% of Holdings
1.6%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Jun 4, 2026
Sale
Shares
200
Price
$539.76
Total Value
$107.95K
Shares Held After
53,272
% of Holdings
0.4%
Jun 4, 2026
Sale
Shares
39,782
Price
$8.97
Total Value
$356.86K
Shares Held After
4,887,491
% of Holdings
0.8%
Jun 4, 2026
Purchase
Shares
25,000
Price
$14.43
Total Value
$360.75K
Shares Held After
3,123,603
% of Holdings
0.8%
Jun 4, 2026
Purchase
Shares
25,000
Price
$14.46
Total Value
$361.50K
Shares Held After
3,098,603
% of Holdings
0.8%

Alkermes plc. (ALKS)

Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Jun 4, 2026
Sale
Shares
2,034
Price
$43.05
Total Value
$87.56K
Shares Held After
229,524
% of Holdings
0.9%
Jun 4, 2026
Sale
Shares
1,234
Price
$95.00
Total Value
$117.23K
Shares Held After
5,598
% of Holdings
18.1%
Jun 4, 2026
Sale
Shares
1,766
Price
$95.00
Total Value
$167.77K
Shares Held After
6,832
% of Holdings
20.5%

Apogee Therapeutics, Inc. (APGE)

Dambkowski Carl — Chief Medical Officer
Jun 3, 2026
Sale
Shares
5,500
Price
$78.71
Total Value
$432.90K
Shares Held After
205,648
% of Holdings
2.6%
Jun 3, 2026
Purchase
Shares
2,500
Price
$17.48
Total Value
$43.70K
Shares Held After
22,500
% of Holdings
11.1%

Ainos, Inc. (AIMD)

chiang yao-chung — Director
Jun 3, 2026
Purchase
Shares
2,000
Price
$2.13
Total Value
$4.26K
Shares Held After
7,779
% of Holdings
25.7%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jun 3, 2026
Sale
Shares
2,566
Price
$102.27
Total Value
$262.42K
Shares Held After
62,344
% of Holdings
4.0%

INSMED Inc (INSM)

Bonstein Sara — Chief Financial Officer
Jun 3, 2026
Sale
Shares
2,404
Price
$102.27
Total Value
$245.86K
Shares Held After
69,082
% of Holdings
3.4%

INSMED Inc (INSM)

Lewis William — Director
Jun 3, 2026
Sale
Shares
7,605
Price
$102.27
Total Value
$777.76K
Shares Held After
265,432
% of Holdings
2.8%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Jun 3, 2026
Sale
Shares
2,159
Price
$102.27
Total Value
$220.80K
Shares Held After
39,454
% of Holdings
5.2%
Jun 3, 2026
Purchase
Shares
250,000
Price
$1.67
Total Value
$418.45K
Shares Held After
1,721,298
% of Holdings
14.5%

INSMED Inc (INSM)

Adsett Roger — Chief Operating Officer
Jun 3, 2026
Sale
Shares
2,370
Price
$102.27
Total Value
$242.38K
Shares Held After
98,603
% of Holdings
2.3%
Jun 3, 2026
Sale
Shares
15,500
Price
$5.90
Total Value
$91.43K
Shares Held After
126,500
% of Holdings
10.9%

DEXCOM INC (DXCM)

Coleman Jon — EVP, Chief Commercial Officer
Jun 3, 2026
Sale
Shares
4,912
Price
$73.00
Total Value
$358.58K
Shares Held After
100,361
% of Holdings
4.7%

Outset Medical, Inc. (OM)

Gaeta Renee — Chief Financial Officer
Jun 3, 2026
Sale
Shares
17,672
Price
$4.94
Total Value
$87.30K
Shares Held After
113,753
% of Holdings
13.4%

Editas Medicine, Inc. (EDIT)

Parison Amy — SVP, Chief Financial Officer
Jun 3, 2026
Sale
Shares
464
Price
$2.70
Total Value
$1.25K
Shares Held After
14,970
% of Holdings
3.0%
Jun 3, 2026
Sale
Shares
15,380
Price
$2.70
Total Value
$41.54K
Shares Held After
248,313
% of Holdings
5.8%

Editas Medicine, Inc. (EDIT)

Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Jun 3, 2026
Sale
Shares
731
Price
$2.70
Total Value
$1.97K
Shares Held After
67,297
% of Holdings
1.1%

Progyny, Inc. (PGNY)

Swartz Allison — EVP, GC
Jun 3, 2026
Sale
Shares
1,199
Price
$25.02
Total Value
$30.00K
Shares Held After
83,316
% of Holdings
1.4%

uniQure N.V. (QURE)

Kaye Jack — Director
Jun 3, 2026
Sale
Shares
2,645
Price
$30.01
Total Value
$79.38K
Shares Held After
20,439
% of Holdings
11.5%
Jun 3, 2026
Purchase
Shares
5,000
Price
$4.09
Total Value
$20.45K
Shares Held After
92,761
% of Holdings
5.4%
Jun 3, 2026
Purchase
Shares
5,000
Price
$4.10
Total Value
$20.50K
Shares Held After
87,761
% of Holdings
5.7%
Jun 3, 2026
Sale
Shares
2,323
Price
$4.26
Total Value
$9.90K
Shares Held After
179,186
% of Holdings
1.3%

OCULAR THERAPEUTIX, INC (OCUL)

Waheed Nadia — Chief Medical Officer
Jun 3, 2026
Sale
Shares
14,828
Price
$8.27
Total Value
$122.63K
Shares Held After
300,079
% of Holdings
4.7%
Jun 3, 2026
Sale
Shares
109,847
Price
$6.24
Total Value
$685.45K
Shares Held After
252,899
% of Holdings
30.3%
Jun 3, 2026
Sale
Shares
1,047,913
Price
$6.24
Total Value
$6.54M
Shares Held After
2,412,602
% of Holdings
30.3%
Jun 3, 2026
Sale
Shares
5,842,240
Price
$6.24
Total Value
$36.46M
Shares Held After
13,450,547
% of Holdings
30.3%
Shares
5,842,240
Price
$6.24
Total Value
$36.46M
Shares Held After
13,450,547
% of Holdings
30.3%
Jun 3, 2026
Sale
Shares
109,847
Price
$6.24
Total Value
$685.45K
Shares Held After
252,899
% of Holdings
30.3%
Jun 3, 2026
Sale
Shares
1,047,913
Price
$6.24
Total Value
$6.54M
Shares Held After
2,412,602
% of Holdings
30.3%
Version: v26.5.2